중동 및 아프리카 세포 및 유전자 치료 해동 장비 시장 – 2028년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

중동 및 아프리카 세포 및 유전자 치료 해동 장비 시장 – 2028년까지의 산업 동향 및 예측

  • Healthcare
  • Published Report
  • Sep 2021
  • MEA
  • 350 Pages
  • 테이블 수: 91
  • 그림 수: 55

>중동 및 아프리카 세포 및 유전자 치료 해동 장비 시장, 방식(탁상형 및 휴대형), 샘플(세포 치료 및 유전자 치료), 유형( 수동 해동 시스템 및 자동 해동 시스템), 응용 분야(상류 처리 및 하류 처리), 최종 사용자( 혈액 은행 및 수혈 센터, 병원 및 진단 실험실, 연구소 및 학술 기관, 생명 공학 및 제약 산업, 제대혈 및 줄기 세포 은행, 유전자 은행 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타), 국가(남아프리카, 사우디 아라비아, UAE, 이집트, 이스라엘 및 중동 및 아프리카의 나머지 지역) 산업 동향 및 2028년까지의 예측.

중동 및 아프리카 세포 및 유전자 치료 해동 장비 시장시장 분석 및 통찰력: 중동 및 아프리카 세포 및 유전자 치료 해동 장비 시장

세포 및 유전자 치료 해동 장비 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 10.8%의 CAGR로 성장하고 있으며 2028년까지 5,883만 달러에 도달할 것으로 예상된다고 분석합니다. 만성 질환의 유병률이 증가함에 따라 고급 세포 및 유전자 치료 해동 장비 솔루션과 서비스가 필요하므로 세포 및 유전자 치료 해동 장비 시장 성장을 견인하는 역할을 합니다.

세포 및 유전자 치료 해동 장비는 기술의 발전으로 인해 쉬워졌는데, 주요 시장 참여자들이 시장을 확대하기 위해 새로운 솔루션을 개발하고 출시하고 있기 때문입니다. 게다가 선진국과 개발도상국에서 의료비가 증가하면서 세포 및 유전자 치료 해동 장비 시장이 성장했습니다. 세포 및 유전자 치료 해동 장비 시장은 만성 질환의 증가와 기술 발전의 증가로 인해 성장하고 있습니다.

만성 질환의 유병률 증가는 세포 및 유전자 치료 해동 장비 시장의 원동력으로 작용합니다. 세포 및 유전자 치료 엔지니어링과 관련된 비용 상승은 세포 및 유전자 치료 해동 장비에 대한 수요를 낮추어 세포 및 유전자 치료 해동 장비 시장 성장을 제한하고 있습니다. 새로운 기술 발전의 급증은 세포 및 유전자 치료 해동 장비 시장에 기회로 작용합니다. 그러나 저소득 및 중소득 국가에서의 접근성 부족은 세포 및 유전자 치료 해동 장비 시장 성장에 대한 과제로 작용합니다.

세포 및 유전자 치료 해동 장비 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 세포 및 유전자 치료 해동 장비 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.

중동 및 아프리카 세포 및 유전자 치료 해동 장비 시장세포 및 유전자 치료 해동 장비 시장 범위 및 시장 규모

세포 및 유전자 치료 해동 장비 시장은 양식, 샘플, 유형, 응용 프로그램, 최종 사용자, 유통 채널을 기준으로 세분화됩니다. 세그먼트 간 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.

  • 샘플을 기준으로 세포 및 유전자 치료 해동 장비 시장은 세포 치료와 유전자 치료로 세분화됩니다. 2021년에는 세포 치료 부문이 암의 유병률과 발생률이 증가함에 따라 세포 및 유전자 치료 해동 장비 시장을 지배할 것으로 예상됩니다. 
  • 세포 및 유전자 치료 해동 장비 시장은 유형을 기준으로 수동 해동 시스템과 자동 해동 시스템으로 세분화됩니다. 2021년에는 자동 해동 시스템 부문이 재현성을 개선하고 인적 오류를 최소화하기 때문에 세포 및 유전자 치료 해동 장비 시장을 지배할 것으로 예상됩니다. 
  • 적용을 기준으로, 세포 및 유전자 치료 해동 장비 시장은 상류 처리 및 하류 처리로 세분화됩니다. 2021년에는 해동 시스템의 기술 발전으로 인해 상류 처리 부문이 세포 및 유전자 치료 해동 장비 시장을 지배할 것으로 예상됩니다. 
  • 최종 사용자를 기준으로 세포 및 유전자 치료 해동 장비 시장은 혈액 은행 및 수혈 센터, 병원 및 진단 실험실, 연구 실험실 및 학술 기관, 생명 공학 및 제약 산업, 탯줄 혈액 및 줄기 세포 은행, 유전자 은행 등으로 세분화됩니다. 2021년에는 혈액 은행 부문이 저소득 및 중소득 국가에서 혈액 은행과 고급 의료 서비스 제공자의 수가 증가함에 따라 세포 및 유전자 치료 해동 장비 시장을 지배할 것으로 예상됩니다.
  • 유통 채널을 기준으로 세포 및 유전자 치료 해동 장비 시장은 직접 입찰, 제3자 유통업체 및 기타로 세분화됩니다. 2021년에는 직접 입찰 부문이 세포 및 유전자 치료 해동 장비 시장을 지배할 것으로 예상되며, 대부분의 의료 서비스 제공자가 직접 입찰에서 세포 및 유전자 치료 해동 장비를 조달하기 때문입니다.

세포 및 유전자 치료 해동 장비 시장 국가 수준 분석

The cell and gene therapy thawing equipment market is segmented on the based on the modality, sample, type, application, end user, distribution channel.

The countries covered in the cell and gene therapy thawing equipment market report are South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa.

South Africa is expected to dominate the market increasing prevalence of chronic diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to Enhance the Awareness for Cell and gene therapy thawing equipment, is Boosting the Market Growth of Cell and Gene Therapy Thawing Equipment Market

The cell and gene therapy thawing equipment market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Cell and Gene Therapy Thawing Equipment Market Share Analysis

Cell and gene therapy thawing equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to cell and gene therapy thawing equipment market.

The major companies which are dealing in the cell and gene therapy thawing equipment are Pluristem Therapeutics Inc., Genesis BPS, Eppendorf AG, Cytiva (A subsidiary of Danaher Corporation), Glenmark Pharmaceutical Inc., USA (A subsidiary of Glenmark), EDGE pharma, Cook, SARSTEDT AG & Co. KG, Barkey, Boekel Scientific, LABCOLD, Sartorious AG and Helmer Scientific Inc. among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the cell and gene therapy thawing equipment market.

For instance,

  • 2020년 11월, Eppendorg AG는 인도에서 세포 해동을 위한 SmartBlock을 출시했습니다. Smart Block Cell Thawing은 다운스트림 프로세싱을 위한 기반입니다. 과학자들이 모든 세포 취급 실험실에서 추가적으로 사용하기 쉽고 편리합니다.

협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략을 통해 세포 및 유전자 치료 해동 장비 시장에서 회사의 입지를 강화하고 있으며, 이는 조직의 수익 성장에도 도움이 됩니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 USAGE OF THAWING EQUIPMENT IN UPSTREAM AND DOWNSTREAM PROCESSES

5.1 UPSTREAM PROCESS

5.2 DOWNSTREAM PROCESS

6 CELL AND GENE THERAPY WORKFLOW USING THAWING EQUIPMENT

7 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: REGULATIONS

7.1 CANADA

7.2 THE U.S.

7.3 EUROPE

7.4 GENE THERAPY LEGISLATION IN AUSTRIA

7.5 GENE THERAPY LEGISLATION IN BULGARIA

7.6 JAPAN

7.7 ITALY

7.8 MALAYSIA

8 REGIONAL SUMMARY

9 MARKET OVERVIEW

9.1 DRIVERS

9.1.1 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CYSTIC FIBROSIS AND SICKLE CELL ANEMIA

9.1.2 RISE IN INVESTMENT IN R&D FOR DEVELOPMENT OF CELL AND GENE THERAPIES

9.1.3 GOVERNMENT INITIATIVES FOR INITIATION OF CELL AND GENE THERAPY FIELD

9.1.4 INCREASED IMPLEMENTATION OF ADENO-ASSOCIATED VIRUS

9.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE THAWING SYSTEMS

9.2 RESTRAINTS

9.2.1 RISE IN COST ASSOCIATED WITH CELL AND GENE THERAPY ENGINEERING

9.2.2 RISE OF UNWANTED MUTAGENS

9.2.3 TECHNICAL HINDRANCE FACED IN USING THAWING INSTRUMENTS

9.2.4 STRICT REGULATORY FRAMEWORK

9.3 OPPORTUNITIES

9.3.1 INCREASING PREVALENCE OF CANCER

9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS

9.3.3 RISE IN EXPENDITURE IN HEALTHCARE SECTOR

9.4 CHALLENGES

9.4.1 LONG APPROVAL TIME FOR IMMUNOTHERAPIES

9.4.2 LACK OF ACCESSIBILITY

10 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

10.1 IMPACT ON PRICE

10.2 IMPACT ON DEMAND

10.3 IMPACT ON SUPPLY CHAIN

10.4 STRATEGIC DECISION FOR MANUFACTURERS

10.5 CONCLUSION

11 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY

11.1 OVERVIEW

11.2 BENCH TOP

11.3 PORTABLE

12 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE

12.1 OVERVIEW

12.2 CELL THERAPIES

12.2.1 CAR T CELLS

12.2.2 NK CELLS

12.2.3 MSCS

12.2.4 TILS

12.2.5 OTHERS

12.3 GENE THERAPIES

12.3.1 ADENOVIRUS

12.3.2 ADENO-ASSOCIATED VIRUSES

12.3.3 LENTIVIRUSES

12.3.4 ONCOLYTIC VIRUSES

12.3.5 OTHERS

13 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE

13.1 OVERVIEW

13.2 AUTOMATIC THAWING SYSTEM

13.3 MANUAL THAWING SYSTEM

14 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION

14.1 OVERVIEW

14.2 UPSTREAM PROCESSING

14.2.1 AUTOMATIC THAWING SYSTEM

14.2.2 MANUAL THAWING SYSTEM

14.3 DOWNSTREAM PROCESSING

14.3.1 AUTOMATIC THAWING SYSTEM

14.3.2 MANUAL THAWING SYSTEM

15 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER

15.1 OVERVIEW

15.2 HOSPITALS AND DIAGNOSTIC LABORATORIES

15.3 BLOOD BANKS AND TRANSFUSION CENTERS

15.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES

15.5 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY

15.6 CORD BLOOD AND STEM CELL BANKS

15.7 GENE BANKS

15.8 OTHERS

16 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 DIRECT TENDER

16.3 THIRD PARTY DISTRIBUTORS

16.4 OTHERS

17 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION

17.1 MIDDLE EAST AND AFRICA

17.1.1 SOUTH AFRICA

17.1.2 SAUDI ARABIA

17.1.3 U.A.E.

17.1.4 EGYPT

17.1.5 ISRAEL

17.1.6 REST OF MIDDLE EAST AFRICA

18 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

19 SWOT ANALYSIS

20 COMPANY PROFILE

20.1 MERCK KGAA

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 PRODUCT PORTFOLIO

20.1.4 RECENT DEVELOPMENTS

20.2 EPPENDORF AG

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 PRODUCT PORTFOLIO

20.2.4 RECENT DEVELOPMENTS

20.3 SARTORIUS AG

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENT

20.4 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)

20.4.1 COMPANY SNAPSHOT

20.4.2 REVENUE ANALYSIS

20.4.3 PRODUCT PORTFOLIO

20.4.4 .RECENT DEVELOPMENTS

20.5 BARKEY

20.5.1 COMPANY SNAPSHOT

20.5.2 PRODUCT PORTFOLIO

20.5.3 RECENT DEVELOPMENTS

20.6 BOEKEL SCIENTIFIC

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 BIOLINE INDIA

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENTS

20.8 COOK

20.8.1 COMPANY SNAPSHOT

20.8.2 PRODUCT PORTFOLIO

20.8.3 RECENT DEVELOPMENT

20.9 GENESIS BPS

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENTS

20.1 HELMER SCIENTIFIC INC.

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENTS

20.11 LABCOLD

20.11.1 COMPANY SNAPSHOT

20.11.2 PRODUCT PORTFOLIO

20.11.3 RECENT DEVELOPMENTS

20.12 PLEURISTEM THERAPEUTICS INC.

20.12.1 COMPANY SNAPSHOT

20.12.2 REVENUE ANALYSIS

20.12.3 PRODUCT PORTFOLIO

20.12.4 RECENT DEVELOPMENTS

20.13 SARSTEDT AG & CO. KG

20.13.1 COMPANY SNAPSHOT

20.13.2 PRODUCT PORTFOLIO

20.13.3 RECENT DEVELOPMENTS

21 QUESTIONNAIRE

22 RELATED REPORTS

표 목록

TABLE 1 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)

TABLE 2 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 3 MIDDLE EAST AND AFRICA BENCH TOP IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA PORTABLE IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA AUTOMATIC THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA MANUAL THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA HOSPITALS AND DIAGNOSTIC LABORATORIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA BLOOD BANKS AND TRANSFUSION CENTERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA CORD BLOOD AND STEM CELL BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA GENE BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA DIRECT TENDER IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTORS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 42 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 43 SOUTH AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 44 SOUTH AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 45 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 SOUTH AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 SOUTH AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 50 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 52 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 53 SAUDI ARABIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 54 SAUDI ARABIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 55 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 SAUDI ARABIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 58 SAUDI ARABIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 62 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 63 U.A.E. CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 64 U.A.E. GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 65 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 U.A.E. UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 U.A.E. DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 70 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 72 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 73 EGYPT CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 74 EGYPT GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 75 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 77 EGYPT UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 EGYPT DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 80 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 82 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 83 ISRAEL CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 84 ISRAEL GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 85 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 87 ISRAEL UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 88 ISRAEL DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 90 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 91 REST OF MIDDLE EAST AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

그림 목록

FIGURE 1 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION

FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CARDIAC AILMENTS, CYSTIC FIBROSIS AND AIDS IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN 2021 & 2028

FIGURE 15 PESTEL ANALYSIS

FIGURE 16 PORTERS FIVE FORCES MODEL

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

FIGURE 18 INCIDENCE OF CYSTIC FIBROSIS OBSERVED IN THE COUNTRIES

FIGURE 19 PREVALENCE OF SICKLE CELL ANEMIA IN AFRICA AND EUROPE

FIGURE 20 NEW CANCER CASES WORLDWIDE, (2018) (IN MILLION)

FIGURE 21 MIDDLE EAST AND AFRICA CANCER INCIDENCE (2018)

FIGURE 22 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2020

FIGURE 23 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2021-2028 (USD MILLION)

FIGURE 24 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, CAGR (2021-2028)

FIGURE 25 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 26 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2020

FIGURE 27 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2021-2028 (USD MILLION)

FIGURE 28 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, CAGR (2021-2028)

FIGURE 29 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY SAMPLE, LIFELINE CURVE

FIGURE 30 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2020

FIGURE 31 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2021-2028 (USD MILLION)

FIGURE 32 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, CAGR (2021-2028)

FIGURE 33 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 34 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2020

FIGURE 35 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 36 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 37 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 38 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2020

FIGURE 39 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 40 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 41 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 43 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 44 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 45 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 46 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SNAPSHOT (2020)

FIGURE 47 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020)

FIGURE 48 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 49 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 50 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY (2021-2028)

FIGURE 51 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENTMARKET: COMPANY SHARE 2020 (%)

FIGURE 52 COMPANY SHARE ANALYSIS

FIGURE 53 COMPANY SHARE ANALYSIS

FIGURE 54 COMPANY SHARE ANALYSIS

FIGURE 55 COMPANY SHARE ANALYSIS

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.